The outpatient medical care in patients with chronic diseases under dispensary supervision in the conditions of the COVID-19 pandemic. Temporary guidelines. Version 2
Open Access
- 11 January 2022
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 20 (8), 3172
- https://doi.org/10.15829/1728-8800-2021-3172
Abstract
Guidelines were approved at the meeting of the academic council of the National Medical Research Center for Therapy and Preventive Medicine, Moscow (Protocol No. 10 of 19.10.2021).The aim of these guidelines is to provide primary care physicians with scientifically based algorithms for the implementation of dispensary monitoring in patients with chronic non-communicable diseases in the conditions of the new coronavirus infection (COVID-19) pandemic, including the use of telemedicine technologies.The organization and conduct of high-quality medical follow-up are the most important tasks aimed at both reducing the risks of developing complications of chronic non-communicable diseases and reducing overall mortality, especially in the current conditions of the COVID-19 pandemic. The guidelines contain clinical aspects of dispensary follow-up, general principles of tactics for managing patients with various chronic non-communicable diseases in COVID-19 conditions, in addition, brief checklists with options for interviewing patients with various chronic non-communicable diseases are presented, topical aspects of the interaction of drugs used in the treatment of chronic non-communicable diseases with antiviral drugs are considered.The guidelines are intended for general practitioners, district therapists, general practitioners (family doctors), as well as doctors of other specialties providing primary health care.Keywords
This publication has 14 references indexed in Scilit:
- Diabetes and COVID-19: analysis of the clinical outcomes according to the data of the russian diabetes registryProblemy Endokrinologii, 2020
- Advances in the relationship between coronavirus infection and cardiovascular diseasesBiomedicine & Pharmacotherapy, 2020
- Practical recommendations for the management of diabetes in patients with COVID-19The Lancet Diabetes & Endocrinology, 2020
- Guidelines for the diagnosis and treatment of circulatory diseases in the context of the COVID-19 pandemicRussian Journal of Cardiology, 2020
- COVID 19 and the Patient with Obesity – The Editors Speak OutObesity, 2020
- The official French guidelines to protect patients with cancer against SARS-CoV-2 infectionThe Lancet Oncology, 2020
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19Journal of Thrombosis and Haemostasis, 2020
- 2019 novel coronavirus (2019-nCoV) outbreak: A new challengeJournal of Global Antimicrobial Resistance, 2020
- A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction ScoreJournal of Thrombosis and Haemostasis, 2010
- Hospitalization for Ambulatory-care-sensitive Conditions in Taiwan Following the SARS Outbreak: A Population-based Interrupted Time Series StudyJournal of the Formosan Medical Association, 2009